Advertisement

Basis and clinical significance of regression of hypertensive hypertrophy

  • W. Motz
  • J. Zähringer
  • B. E. Strauer
Conference paper

Summary

The basis of every therapy in hypertensive heart disease is blood pressure normalization. However, blood pressure should be lowered through antihypertensive drugs, which can a) regress LV hypertrophy, b) increase myocardial perfusion and c) improve LV function depending on the stage of hypertensive heart disease. Such a step-care of hypertensive heart disease must not be understood as a therapeutic scheme, but should be considered as an attempt to cover the clinical therapy of common hypertensive cardiac complications.

Key words

LV hypertrophy antihypertensive therapy myocardial protein synthesis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Alcocer L, Aspe J (1979) The effect of antihypertensive treatment with alpha-methyldopa on left ventricular mass. In: Robertson JIS, Caldwell ADS (eds) Left ventricular hypertrophy in hypertension. Royal Society of Medicine International Congress and Symposium Series No. 9, Academic Press (London), and Grune & Stratton, pp 94–97Google Scholar
  2. 2.
    Beznak M, Korecky B, Thomas G (1969) Regression of cardiac hypertrophies of various origin. Can J Physiol Pharmacol 47: 579–586PubMedCrossRefGoogle Scholar
  3. 3.
    Danninger B, Stangl E, Aschauer W, Motz W, Strauer BE, Zähringer J (1985) Herzmuskelhypertrophie — Regression und Veränderungen der myokardialen Genexpression unter Nifedipin-Gabe. Z Kardiol 74 (Suppl 3): 62Google Scholar
  4. 4.
    Devereux RB, Savage DD, Sachs J, Laragh JH (1980) Effect of blood pressure control on left ventricular hypertrophy and function in hypertension. Circulation 62 (Suppl II): II - 36Google Scholar
  5. 5.
    Drayer JIM, Gardin JM, Weber MA, Aronow WS (1982) Changes in cardiac anatomy and function during therapy with alpha-methyldopa: an echocardiographic study. Curr Ther Res 32: 856–865Google Scholar
  6. 6.
    Drayer JIM, Weber MA, Gardin JM, Lipson JL (1983) Effect of long-term antihypertensive therapy on cardiac anatomy in patients with essential hypertension. Am J Med 75 (Suppl 3A): 116PubMedCrossRefGoogle Scholar
  7. 7.
    Fouad FM, Nakashima Y, Tarazi RC, Salcedo EE (1982) Reversal of left ventricular hypertrophy in hypertensive patients treated with alpha-methyldopa: lack of association with blood pressure control. Am J Cardiol 49: 795PubMedCrossRefGoogle Scholar
  8. 8.
    Fouad FM, Tarazi RC, Bravo EL (1983) Hemodynamic and cardiac effects of enalapril. J. Hypertension 1 (Suppl 1): 135Google Scholar
  9. 9.
    Hess OM, Riter M, Schneider J, Grimm J, Turina M, Krayenbühl HP (1983) Diastolic myocardial stiffness and myocardial structure in aortic valve disease before and after value replacement. J Am Coll Cardiol 1 (2): 640Google Scholar
  10. 10.
    Laks MN, Morady F (1976) Norepinephrine — the myocardial hypertrophy hormone? Am Heart J 91: 674–675PubMedCrossRefGoogle Scholar
  11. 11.
    Lederle RM, Klaus D, Tegenthoff M (1984) Die Rückbildung der Linksherzhypertrophie unter Captopril bei Patienten mit therapieresistenter Hypertonie. Herz/Kreislauf 2: 73Google Scholar
  12. 12.
    Motz W, Ploeger M, Strauer BE (1983) The effect of nifedipine on cardiac function in acute pulmonary embolism. Circulation 68 (Suppl III): 36Google Scholar
  13. 13.
    Motz W, Strauer BE (1984) Regression of structural cardiovascular changes by antihypertensive therapy. Hypertension 6 (Suppl III): 133–139CrossRefGoogle Scholar
  14. 14.
    Motz W, Strauer BE (1985) Prevention of left ventricular hypertrophy by antihypertensive therapy in spontaneously hypertensive rats: effects on systolic wall stress and systolic function. Basic Res Cardiol (in press)Google Scholar
  15. 15.
    Mujais SK, Tarazi RC, Rouad FM, Bravo EL (1983) Reversal of left ventricular hypertrophy with captopril. Clin Cardiol 6: 595PubMedCrossRefGoogle Scholar
  16. 16.
    Nakashima MAJ, Fouad FM, Tarazi RC (1984) Regression of left ventricular hypertrophy from systemic hypertension by enalapril. Am J Cardiol 53: 1044PubMedCrossRefGoogle Scholar
  17. 17.
    Pfeffer JM, Pfeffer MA, Fletcher P, Fishbein M, Brawald E (1982) Favorable effects of therapy on cardiac performance in spontaneously hypertensive rats. Am J Physiol 242: H776PubMedGoogle Scholar
  18. 18.
    Sen S, Tarazi RC, Khairallah PA, Bumpus FM (1974) Cardiac hypertrophy in spontaneously hypertensive rats. Circ Res 35: 775PubMedCrossRefGoogle Scholar
  19. 19.
    Sen S, Tarazi RC, Bumpus FM (1977) Cardiac hypertrophy and antihypertensive therapy. Cardiovase Res 11: 427CrossRefGoogle Scholar
  20. 20.
    Spech M, Ferrano CM, Tarazi RC (1980) Cardiac pumping ability following reversal of hypertrophy and hypertension in spontaneously hypertensive rats. Hypertension 2: 75PubMedCrossRefGoogle Scholar
  21. 21.
    Strauer BE (1979) Myocardial oxygen consumption in chronic heart disease: Role of wall stress, hypertrophy and coronary reserve. Am J Cardiol 44: 730PubMedCrossRefGoogle Scholar
  22. 22.
    Strauer BE (1983) Das Hochdruckherz, 2nd ed. Springer-Verlag, BerlinGoogle Scholar
  23. 23.
    Strauer BE (1985) Neue Ergebnisse in der Therapie der hypertensiven Herzkrankheit. Therapiewoche (in press)Google Scholar
  24. 24.
    Strauer BE, Mahmoud MA, Bayer F, Bohn I, Motz U (1984) Reversal of left ventricular hypertrophy and improvement of cardiac function in man by nifedipine. Eur Heart 5 (Suppl I): 53CrossRefGoogle Scholar
  25. 25.
    Trimarco B, Wikstrand J (1984) Regression of cardiovascular structural changes by antihypertensive treatment. Hypertension 6 (Suppl III): 111–150CrossRefGoogle Scholar
  26. 26.
    Wollam GL et al. (1982) Diuretic potency of combined hydrochlorothiazide and furosemide therapy in patients with azotemia. Am J Med 72 (6): 929PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • W. Motz
    • 1
  • J. Zähringer
    • 2
  • B. E. Strauer
    • 3
  1. 1.Lehrstuhl für innere Medizin, Schwerpunkt KardiologiePhilipps-Universität Marburg, Klinikum LahnbergeMarburg/LahnGermany
  2. 2.Medizinische Klinik IUniversität MünchenGermany
  3. 3.Zentrum für Innere MedizinPhilipps-Universität MarburgGermany

Personalised recommendations